Molecular detection of Parachlamydia-like organisms in cerebrospinal fluid of patients with multiple sclerosis
- PMID: 18562511
- DOI: 10.1177/1352458507085796
Molecular detection of Parachlamydia-like organisms in cerebrospinal fluid of patients with multiple sclerosis
Abstract
The presence of Chlamydia-like organism DNA was investigated by polymerase chain reaction (PCR) in cerebrospinal fluid (CSF) samples from 27 patients previously found positive for Chlamydia pneumoniae DNA: 12 with multiple sclerosis (MS), grouped according to clinical and magnetic resonance imaging (MRI) evidence of disease activity, 8 with other inflammatory neurological disorders and 7 with non-inflammatory neurological disorders. PCR evidence of Chlamydia-like organisms in CSF was observed only in two relapsing-remitting MS patients with clinical and MRI disease activity. These findings suggest a possible association between C. pneumoniae and Chlamydia-like organism brain infections as a cofactor in MS development.
Similar articles
-
Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.J Neurol. 2004 May;251(5):542-7. doi: 10.1007/s00415-004-0360-0. J Neurol. 2004. PMID: 15164186
-
Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis.Neurosci Res. 2008 Sep;62(1):58-61. doi: 10.1016/j.neures.2008.05.003. Epub 2008 May 20. Neurosci Res. 2008. PMID: 18572268
-
Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis.Mult Scler. 2004 Aug;10(4):360-9. doi: 10.1191/1352458504ms1049oa. Mult Scler. 2004. PMID: 15327030
-
PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid.Mult Scler. 2008 Mar;14(2):147-52. doi: 10.1177/1352458507082149. Epub 2007 Nov 6. Mult Scler. 2008. PMID: 17986505 Review.
-
Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis.Curr Neurovasc Res. 2008 Feb;5(1):60-70. doi: 10.2174/156720208783565609. Curr Neurovasc Res. 2008. PMID: 18289023 Review.
Cited by
-
Chlamydia Outer Protein (Cop) B from Chlamydia pneumoniae possesses characteristic features of a type III secretion (T3S) translocator protein.BMC Microbiol. 2015 Aug 14;15:163. doi: 10.1186/s12866-015-0498-1. BMC Microbiol. 2015. PMID: 26272448 Free PMC article.
-
Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.PLoS One. 2019 Apr 9;14(4):e0214738. doi: 10.1371/journal.pone.0214738. eCollection 2019. PLoS One. 2019. PMID: 30964886 Free PMC article.
-
Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.Interdiscip Perspect Infect Dis. 2010;2010:273573. doi: 10.1155/2010/273573. Epub 2010 Feb 21. Interdiscip Perspect Infect Dis. 2010. PMID: 20182626 Free PMC article.
-
A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.BMC Microbiol. 2009 Oct 14;9:218. doi: 10.1186/1471-2180-9-218. BMC Microbiol. 2009. PMID: 19828035 Free PMC article.
-
Evaluation of APR1 Gene Expression in Candida albicans Strains Isolated From Patients With Multiple Sclerosis.Jundishapur J Microbiol. 2016 Apr 9;9(5):e33292. doi: 10.5812/jjm.33292. eCollection 2016 May. Jundishapur J Microbiol. 2016. PMID: 27540458 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources